Bernardo Gindri: How platelets Influence Cancer Progression
Bernardo Gindri, Postdoctoral Fellow at NYU Langone Health, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Advances, adding:
“If you want to learn more about how platelets influence cancer progression and antitumor immunity, check out our latest review,
‘Tumor-platelet cross talk in cancer: mechanisms, thrombotic risk, and translational opportunities,’ published in Blood Advances.
We bring together current mechanistic and translational evidence on how tumors reprogram platelets, how platelets shape the tumor microenvironment and metastatic process, and how these interactions may be leveraged for biomarker development and new therapeutic strategies.
Thank you Tessa Barrett for your support and mentorship, and Zihang Li for helping put this work together!”
Title: Tumor-platelet cross talk in cancer: mechanisms, thrombotic risk, and translational opportunities
Authors: Bernardo Gindri dos Santos, Zihang Li, Tessa J. Barrett
Stay updated with Hemostasis Today.
-
Oct 6, 2026, 04:07Moussa Zein Aldine: Acute Coronary Syndrome Every Minute Matters
-
Oct 6, 2026, 03:13Patrick Taylor: Glow Stack Trend What the Evidence Really Shows
-
Oct 6, 2026, 02:59Preventing Hospital Associated Venous Thromboembolism – Thrombosis Canada
-
Oct 6, 2026, 02:42Treatment of Iron Deficiency With and Without Anemia – American Society of Hematology
-
Oct 6, 2026, 02:36Mouna Sassi: When Clinical and Laboratory Perspectives Meet in Thrombosis Care
-
Oct 6, 2026, 02:35Lucia Stefanini: Platelet Dysfunction and Oxidized Phospholipids in MASLD
-
Oct 6, 2026, 02:18Pablo Corral: Association of Lp(a) With Coronary Atherosclerosis and CV Events
-
Oct 5, 2026, 22:55Steve Humphreys: A Big Thank You to BSHT for Providing Me With a Recent Skills Exchange Award
-
Oct 5, 2026, 22:52William McKeown: Great to Be in Istanbul for the Opening of the EHC 2026